Neoadjuvant chemoradiotherapy (NCRT) has shown promise in improving the prognosis of individuals with locally
advanced esophageal squamous cell carcinoma (LA-ESCC). However, the factors influencing tumor response and
long-term survival in these patients remain unknown. The optimal timing for surgery after the completion of
radiotherapy in LA-ESCC remains controversial. Therefore, this study aimed to identify biomarkers and determine
the optimal post-NCRT time-to-surgery (TTS) for patients with LA-ESCC.
语种：
外文
WOS：
中科院(CAS)分区：
出版当年[2025]版：
大类|2 区医学
小类|2 区肿瘤学2 区核医学
最新[2025]版：
大类|2 区医学
小类|2 区肿瘤学2 区核医学
JCR分区：
出版当年[2024]版：
Q1ONCOLOGYQ1RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING
最新[2024]版：
Q1ONCOLOGYQ1RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING
第一作者机构：[1]Sichuan Canc Ctr, Radiat Oncol, Chengdu, Peoples R China[2]Radiat Oncol Key Lab, Chengdu, Sichuan, Peoples R China
推荐引用方式(GB/T 7714)：
Wang Qifeng,Li Jingqiu,Zhou Xiaoding,et al.Optimal Time-to-Surgery for Patients with Esophageal Cancer after Neoadjuvant Chemoradiotherapy[J].RADIOTHERAPY AND ONCOLOGY.2024,194:S2143-S2146.
APA：
Wang, Qifeng,Li, Jingqiu,Zhou, Xiaoding,Liu, Ying,Zhu, Jie...&Han, Yongtao.(2024).Optimal Time-to-Surgery for Patients with Esophageal Cancer after Neoadjuvant Chemoradiotherapy.RADIOTHERAPY AND ONCOLOGY,194,
MLA：
Wang, Qifeng,et al."Optimal Time-to-Surgery for Patients with Esophageal Cancer after Neoadjuvant Chemoradiotherapy".RADIOTHERAPY AND ONCOLOGY 194.(2024):S2143-S2146
医学